CL2012000493A1 - Procedimiento de preparacion de 2-alquilamino-3-piridin-n-bencilpiperazin cetonas. - Google Patents

Procedimiento de preparacion de 2-alquilamino-3-piridin-n-bencilpiperazin cetonas.

Info

Publication number
CL2012000493A1
CL2012000493A1 CL2012000493A CL2012000493A CL2012000493A1 CL 2012000493 A1 CL2012000493 A1 CL 2012000493A1 CL 2012000493 A CL2012000493 A CL 2012000493A CL 2012000493 A CL2012000493 A CL 2012000493A CL 2012000493 A1 CL2012000493 A1 CL 2012000493A1
Authority
CL
Chile
Prior art keywords
benzylpiperazine
alkylamino
ketones
pyridine
procedure
Prior art date
Application number
CL2012000493A
Other languages
English (en)
Inventor
Sripathy Venkatraman
Syed Mahmood
Bingidimi I Mobele
Olga Lapina
Kellie Vercoe
Ying Li
Jonathan Salsbury
M Mclaws
Original Assignee
Neuralstem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43649584&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012000493(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neuralstem Inc filed Critical Neuralstem Inc
Publication of CL2012000493A1 publication Critical patent/CL2012000493A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Un método para sintetizar un compuesto derivado de piperazina disustituida con bencilo y ácido nicotínico, útiles para el tratamiento de condiciones neurológicas.
CL2012000493A 2009-08-24 2012-02-24 Procedimiento de preparacion de 2-alquilamino-3-piridin-n-bencilpiperazin cetonas. CL2012000493A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23647709P 2009-08-24 2009-08-24

Publications (1)

Publication Number Publication Date
CL2012000493A1 true CL2012000493A1 (es) 2012-09-28

Family

ID=43649584

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012000493A CL2012000493A1 (es) 2009-08-24 2012-02-24 Procedimiento de preparacion de 2-alquilamino-3-piridin-n-bencilpiperazin cetonas.

Country Status (23)

Country Link
US (2) US9278933B2 (es)
EP (1) EP2470182B1 (es)
JP (1) JP5727482B2 (es)
KR (1) KR101701362B1 (es)
CN (2) CN105693601A (es)
AU (1) AU2010289802C1 (es)
BR (1) BR112012004161B1 (es)
CA (1) CA2772080C (es)
CL (1) CL2012000493A1 (es)
DK (1) DK2470182T3 (es)
ES (1) ES2475721T3 (es)
HK (1) HK1172844A1 (es)
HR (1) HRP20140621T1 (es)
IL (1) IL218298A (es)
IN (1) IN2012DN02370A (es)
MX (1) MX2012002335A (es)
NZ (1) NZ598891A (es)
PL (1) PL2470182T3 (es)
PT (1) PT2470182E (es)
RU (1) RU2567390C2 (es)
SG (1) SG178867A1 (es)
SI (1) SI2470182T1 (es)
WO (1) WO2011028548A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105693601A (zh) * 2009-08-24 2016-06-22 纽若斯丹公司 神经刺激性哌嗪的合成
JP7204640B2 (ja) * 2016-09-12 2023-01-16 ニューラルステム・インコーポレーテッド 糖尿病に関連する神経障害の改善
US20180104240A1 (en) * 2016-10-18 2018-04-19 Neuralstem, Inc. Amelioration of radiation-induced cognitive dysfunction
US10042957B2 (en) 2017-01-12 2018-08-07 Innovationdock, Inc. Devices and methods for implementing dynamic collaborative workflow systems
US10413534B2 (en) * 2017-02-13 2019-09-17 Neuralstem, Inc. Amelioration of certain deficiencies due to stroke
US20240067625A1 (en) * 2020-12-23 2024-02-29 Baylor College Of Medicine Small-molecule modulators of the orphan nuclear receptor tlx
CA3219364A1 (en) 2021-06-03 2022-12-08 Alto Neuroscience, Inc. Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agent

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU175075B (hu) * 1977-06-30 1980-05-28 Egyt Gyogyszervegyeszeti Gyar Sposob poluchenija piperazidov piridin-karbonovoj kisloty
JPS54122283A (en) * 1978-03-13 1979-09-21 Sumitomo Chem Co Ltd Novel quinazoline derivative and its preparation
US6995162B2 (en) * 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
DE60330323D1 (de) * 2002-03-29 2010-01-14 Schering Corp Stereoselektive alkylierung von chirale 2-methyl-4-geschützte piperazinen
GB0222493D0 (en) * 2002-09-27 2002-11-06 Glaxo Group Ltd Compounds
US20040185429A1 (en) * 2002-12-09 2004-09-23 Judith Kelleher-Andersson Method for discovering neurogenic agents
CA2537292C (en) * 2003-09-09 2013-04-02 F. Hoffmann-La Roche Ag 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
NZ554441A (en) * 2004-10-29 2009-07-31 Banyu Pharma Co Ltd Novel aminopyridine derivatives having aurora A selective inhibitory action
US7754724B2 (en) 2005-06-30 2010-07-13 Dow Agrosciences Llc N-substituted piperazines
WO2007071358A1 (en) * 2005-12-20 2007-06-28 Novartis Ag Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
CN105693601A (zh) * 2009-08-24 2016-06-22 纽若斯丹公司 神经刺激性哌嗪的合成

Also Published As

Publication number Publication date
US9278933B2 (en) 2016-03-08
EP2470182B1 (en) 2014-06-04
ES2475721T3 (es) 2014-07-11
JP5727482B2 (ja) 2015-06-03
RU2567390C2 (ru) 2015-11-10
KR101701362B1 (ko) 2017-02-01
NZ598891A (en) 2014-05-30
BR112012004161A2 (pt) 2016-03-29
PL2470182T3 (pl) 2015-05-29
AU2010289802A1 (en) 2012-04-12
US20130005974A1 (en) 2013-01-03
HK1172844A1 (en) 2013-05-03
EP2470182A1 (en) 2012-07-04
US20160090358A1 (en) 2016-03-31
PT2470182E (pt) 2014-07-24
AU2010289802B2 (en) 2014-10-02
CA2772080C (en) 2017-05-30
IL218298A (en) 2017-03-30
AU2010289802C1 (en) 2015-04-16
EP2470182A4 (en) 2013-04-24
SI2470182T1 (sl) 2014-10-30
WO2011028548A1 (en) 2011-03-10
JP2013502462A (ja) 2013-01-24
MX2012002335A (es) 2012-07-04
RU2012111227A (ru) 2013-10-10
SG178867A1 (en) 2012-04-27
CN105693601A (zh) 2016-06-22
CN102711764A (zh) 2012-10-03
CA2772080A1 (en) 2011-03-10
IN2012DN02370A (es) 2015-08-21
HRP20140621T1 (hr) 2014-11-21
US9481649B2 (en) 2016-11-01
BR112012004161B1 (pt) 2020-04-07
IL218298A0 (en) 2012-04-30
KR20120054642A (ko) 2012-05-30
DK2470182T3 (da) 2014-07-21

Similar Documents

Publication Publication Date Title
CL2012000493A1 (es) Procedimiento de preparacion de 2-alquilamino-3-piridin-n-bencilpiperazin cetonas.
MX2012005358A (es) Procedimiento para la preparacion de etexilato de dabigatran.
ZA201004848B (en) Method for the production of disubstituted imidazolium salts
EA201170872A1 (ru) Ингибиторы протеинкиназы
MY156274A (en) COMPOUNDS FOR THE REDUCTION OF ß-AMYLOID PRODUCTION
BRPI1008021A2 (pt) Método para fabricação de 2,6-dioxabiciclo-(3.3.0)-octano-4,8-diona
MX341456B (es) Amino-quinolinas como inhibidores de cinasa.
MX353257B (es) Compuestos heterociclicos utiles como inhibidores de proteina cinasa-1 dependiente de 3-fosfoinositido (pdk1).
EA201270149A1 (ru) Ингибиторы bace
EP2566477A4 (en) AMINO-QUINOLINES AS KINASE INHIBITORS
GEP20135933B (en) Compounds as bradykinin b1 antagonists
TN2012000248A1 (en) Novel spiropiperidine compounds
UA104438C2 (uk) Спосіб одержання дабігатрану і його проміжних сполук
TN2014000058A1 (en) A Novel 1,2,3,4-Tetrahydroquinoline Derivative Useful for the Treatment of Diabetes
EA201270280A1 (ru) Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
MX370253B (es) Composiciones de compuestos de jasmonato y métodos de uso de las mismas.
GEP20135960B (en) New method of synthesis of ivabradine and pharmaceutically acceptable acid-additive salts thereof
MX2011011776A (es) Nuevos profarmacos de triptolite.
MX2013002851A (es) Inhibidores de tonum pectinacetilesterasa y metodos de su uso.
WO2010102154A3 (en) Biaryl oxyacetic acid compounds
WO2010098583A3 (ko) 스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물
PH12016501704A1 (en) Method for producing 2-acyliminopyridine derivative
UY34386A (es) Método para la producción de ácido láctico
UA117524C2 (uk) Стимулятори рослин, їх застосування та спосіб стимуляції рослин
MX2012005733A (es) Metodo de produccion de derivados de acido glutamico marcados con f-18.